Merck 4Q10 4Q Revenues: $12.1 billion (+20%)* 4Q Loss: $531 million (earnings of $6.5 billion in 2009) FY Revenues: $46.0 billion (+68%)* FY Earnings: $982 million (earnings of $13.0 billion in 2009) Comments: Revenues and earnings were skewed as a result of the Schering-Plough acquisition, which closed in 4Q09. Pro-rated figures would have left human health revenues down 2% for 4Q and -1% for FY. Cozaar/Hyzaar posted a 57% drop in sales in 4Q ($415 million) and fell 41% for FY ($...